PVLA Palvella Therapeutics, Inc. Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Palvella Therapeutics (PVLA) Stock: Buy, Sell, or Hold?

$163.94
-4.77 (-2.83%) ▼
5d: +1.02% 30d: +27.57% 90d: +4.72%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (42%)
Quality Score
33/100
Position
EXTENDED
30-Day Fair Range
$123.44 – $156.87
Position: EXTENDED
Forward P/E & Valuation
-20.3x
Next 12M consensus est.
Wall Street Target
$233.80
+42.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$141.98 / $179.95
Trend: Sideways
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: PVLA shows conflicting indicators. Wait for confirmation before entering.

Get Alerted When PVLA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: PVLA is currently trading at $163.94, which is considered extended relative to its 30-day fair value range of $123.44 to $156.87.

Technical Outlook: Technically, PVLA is showing sideways momentum. Immediate support is located at $141.98, while resistance sits at $179.95.

Market Sentiment: PVLA scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $233.80 (+42.6%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $123.44 - $156.87
Company Quality Score 33/100 (SELL)
Volume Confirmation HIGH
Confidence Score 41.7%

Trading Range & Key Levels

30-Day Trading Range $123.44 - $156.87
Current vs Trading Range EXTENDED
Expected Move (7 Days) ±$12.09 (7.4%)
Support Level $141.98
Resistance Level $179.95
Current Trend Sideways
Technical data as of Nov 11, 2026

Quantitative Signal Breakdown

  • BEARISH: Price extended above range
  • BULLISH: Options cheap (IV 0th percentile)
  • BEARISH: Weak technical setup (0/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 42.6% below Wall St target ($233.80)
  • WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -20.31
Wall Street Target $233.80 (+42.6%)
Share PVLA Analysis

Share this live PVLA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (PVLA)

Bullish 1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 7, 2026
Daily AI digest
AI Retail Discussion Summary: Bullish sentiment on StockTwits as traders anticipate $PVLA reaching $185. No recent news articles available.
Key Retail Themes: Anticipated stock price increase
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 7:52 PM ET
Data refreshes hourly during market hours. Next update: 8:52 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for PVLA.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
CYTK
Cytokinetics Inc
STRONG BUY
22 analysts
$107 61 BUY
INSM
Insmed Inc
STRONG BUY
24 analysts
$194 37 SELL
MDGL
Madrigal Pharmaceuticals…
STRONG BUY
19 analysts
$689 56 HOLD
CRNX
Crinetics Pharmaceutical…
STRONG BUY
17 analysts
$86 46 HOLD
RCUS
Arcus Biosciences Inc
STRONG BUY
15 analysts
$41 63 BUY

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive PVLA Research Pages
PVLA Technical Chart PVLA Price Prediction PVLA Intrinsic Value DCF PVLA Earnings Date Why is PVLA Moving Today? PVLA Investment Advisor PVLA Fair Price Analyzer PVLA Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals